Expression of human CXCR2 in murine neutrophils as a model for assessing cytomegalovirus chemokine vCXCL-1 function in vivo

Journal of Interferon and Cytokine Research

Volumn 24, Issue 10, 2004, Pages 611-620

  Sparer, Tim E ^a,c   Gosling, Jennifa ^b   Schall, Thomas J ^b   Mocarski, Edward S ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ChemoCentryx Inc   (United States)

^c UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCL1; CHEMOKINE RECEPTOR CXCL8; CHEMOKINE RECEPTOR CXCR2; HUMAN MYELOID RELATED PROTEIN 8; PROTEIN; THIOGLYCOLIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CALCIUM TRANSPORT; CHEMOTAXIS; CYTOMEGALOVIRUS; GENE EXPRESSION; GENE FUNCTION; HUMAN; IN VIVO STUDY; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; VIRUS INFECTION;

ANIMALS; CHEMOKINES, CXC; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; MODELS, IMMUNOLOGICAL; NEUTROPHILS; RECEPTORS, INTERLEUKIN-8B; RECOMBINANT PROTEINS;

ANIMALIA; CYTOMEGALOVIRUS; EUKARYOTA; HUMAN HERPESVIRUS 5; MURINAE; MUS MUSCULUS;

EID: 4944244783     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/1079990042280883     Document Type: Article

References (47)

1. PASS, R.F. (2001) Cytomegalovirus. In: Fields Virology, 4th ed. D. Knipe and P. Howley (eds.) Philadelphia: Lippincott Williams & Wilkins, pp. 2675-2705.
2. HOLLAND, G.N. (1985). Ocular manifestations of the acquired immune deficiency syndrome. Int. Ophthalmol. Clin. 25, 179-187.
3. GRATTAN, M.T., MORENO-CABRAL, C.E., STARNES, V.A., OYER, P.E., STINSON, E.B., and SHUMWAY, N.E. (1989). Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 261, 3561-3566.
4. FIALA, M., PAYNE, J.E., BERNE, T.V., MOORE, T.C., HENLE, W., MONTGOMERIE, J.Z., CHATTERJEE, S.N., and GUZE, L.B. (1975). Epidemiology of cytomegalovirus infection after transplantation and immunosuppression. J. Infect. Dis. 132, 421-433.
5. GERNA, G., PERCIVALLE, E., BALDANTI, F., SOZZANI, S., LANZARINI, P., GENINI, E., LILLERI, D., and REVELLO, M.G. (2000). Human cytomegalovirus replicates abortively in polymorphonuclear leukocytes after transfer from infected endothelial cells via transient microfusion events. J. Virol. 74, 5629-5638.
6. WALDHOER, M., KLEDAL, T.N., FARRELL, H., and SCHWARTZ, T.W. (2002). Murine cytomegalovirus (CMV) M33 and human CMV US28 receptors exhibit similar constitutive signaling activities. J. Virol. 76, 8161-8168.
7. KOTENKO, S.V., SACCANI, S., IZOTOVA, L.S., MIROCHNITCHENKO, O.V., and PESTKA, S. (2000), Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc. Natl. Acad. Sci. USA 97, 1695-1700,
8. PENFOLD, M.E., DAIRAGHI, D.J., DUKE, G.M., SAEDERUP, N., MOCARSKI, E.S., KEMBLE, G.W., and SCHALL, T.J. (1999). Cytomegalovirus encodes a potent alpha chemokine. Proc. Natl. Acad. Sci. USA 96, 9839-9844.
9. TAYLOR-WIEDEMAN, J., SISSONS, J.G., BORYSIEWICZ, L.K., and SINCLAIR, J.H. (1991). Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J. Gen. Virol. 72, 2059-2064.
10. GERNA, G., ZIPETO, D., PERCIVALLE, E., PAREA, M., REVELLO, M. G., MACCARIO, R., PERI, G., and MILANESI, G. (1992). Human cytomegalovirus infection of the major leukocyte subpopulations and evidence for initial viral replication in polymorphonuclear leukocytes from viremic patients. J. Infect. Dis. 166, 1236-1244.
11. REVELLO, M.G., PERCIVALLE, E., ARBUSTINI, E., PARDI, R., SOZZANI, S., and GERNA, G. (1998). In vitro generation of human cytomegalovirus pp65 antigenemia, viremia, and leuko-DNAemia. J. Clin. Invest. 101, 2686-2692.
12. RANDOLPH-HABECKER, J.R., RAHILL, B., TOROK-STORB, B., VIEIRA, J., KOLATTUKUDY, P.E., ROVIN, B.H., and SEDMAK, D.D. (2002). The expression of the cytomegalovirus chemokine receptor homolog US28 sequesters biologically active CC chemokines and alters IL-8 production. Cytokine 19, 37-46.
13. FROBERG, M.K., ADAMS, A., SEACOTTE, N., PARKER-THORNBURG, J., and KOLATTUKUDY, P. (2001). Cytomegalovirus infection accelerates inflammation in vascular tissue overexpressing monocyte chemoattractant protein-1. Circ. Res. 89, 1224-1230.
14. BAGGIOLINI, M., and LOETSCHER, P. (2000). Chemokines in inflammation and immunity. Immunol. Today 21, 418-420.
15. MURPHY, P.M. (2002). International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature. Pharmacol. Rev. 54, 227-229.
16. CHA, T.A., TOM, E., KEMBLE, G.W., DUKE, G.M., MOCARSKI, E.S., and SPAETE, R.R. (1996). Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J. Virol. 70, 78-83.
17. PRICHARD, M.N., PENFOLD, M.E., DUKE, G.M., SPAETE, R.R., and KEMBLE, G.W. (2001). A review of genetic differences between limited and extensively passaged human cytomegalovirus strains. Rev. Med. Virol. 11, 191-200.
18. BACON, K., BAGGIOLINI, M., BROXMEYER, H., HORUK, R., LINDLEY, I., MANTOVANI, A., MAYSUSHIMA, K., MURPHY, P., NOMIYAMA, H., OPPENHEIM, J., ROT, A., SCHALL, T., TSANG, M., THORPE, R., VAN DAMME, J., WADHWA, M., YOSHIE, O., ZLOTNIK, A., and ZOON, K. (2002). Chemokine/chemokine receptor nomenclature. J. Interferon Cytokine Res. 22, 1067-1068.
19. SAEDERUP, N., AGUIRRE, S.A., SPARER, T.E., BOULEY, D.M., and MOCARSKI, E.S. (2001). Murine cytomegalovirus CC chemokine homolog MCK-2 (m131-129) is a determinant of dissemination that increases inflammation at initial sites of infection. J. Virol. 75, 9966-9976.
20. STREBLOW, D.N., KREKLYWICH, C., YIN, Q., DE LA MELENA, V.T., CORLESS, C.L., SMITH, P.A., BRAKEBILL, C., COOK, J.W., VINK, C., BRUGGEMAN, C.A., NELSON, J.A., and ORLOFF, S.L. (2003). Cytomegalovirus-mediated upregulation of chemokine expression correlates with the acceleration of chronic rejection in rat heart transplants. J. Virol. 77, 2182-2194.
21. DAVISON, A.J., DOLAN, A., AKTER, P., ADDISON, C., DARGAN, D.J., ALCENDOR, D.J., McGEOCH, D.J., and HAYWARD, G.S. (2003). The human cytomegalovirus genome revisited: comparison with the chimpanzee cytomegalovirus genome. J. Gen. Virol. 84, 17-28.
22. ALCAMI, A., and KOSZINOWSKI, U.H. (2000). Viral mechanisms of immune evasion. Trends Microbiol. 8, 410-418.
23. MOCARSKI, E.S., Jr, (2002). Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion. Trends Microbiol. 10, 332-339.
24. FLEMING, P., DAVIS-POYNTER, N., DEGLI-ESPOSTI, M., DENSLEY, E., PAPADIMITRIOU, J., SHELLAM, G., and FARRELL, H. (1999). The murine cytomegalovirus chemokine homolog, m131/129, is a determinant of viral pathogenicity. J. Virol. 73, 6800-6809.
25. MACDONALD, M.R., BURNEY, M.W., RESNICK, S.B., and VIRGIN, H.I. (1999). Spliced mRNA encoding the murine cytomegalovirus chemokine homolog predicts a beta chemokine of novel structure. J. Virol. 73, 3682-3691.
26. SAEDERUP, N., LIN, Y.C., DAIRAGHI, D.J., SCHALL, T.J., and MOCARSKI, E.S. (1999). Cytomegalovirus-encoded beta chemokine promotes monocyte-associated viremia in the host. Proc. Natl. Acad. Sci. USA 96, 10881-10886.
27. BONECCHI, R., FACCHETTI, F., DUSI, S., LUINI, W., LISSANDRINI, D., SIMMELINK, M., LOCATI, M., BERNASCONI, S., ALLAVENA, P., BRANDT, E., ROSSI, F., MANTOVANI, A., and SOZZANI, S. (2000). Induction of functional IL-8 receptors by IL-4 and IL-13 in human monocytes. J. Immunol. 164, 3862-3869.
28. PATEL, L., CHARLTON, S.J., CHAMBERS, J.K., and MACPHEE, C.H. (2001). Expression and functional analysis of chemokine receptors in human peripheral blood leukocyte populations. Cytokine 14, 27-36.
29. LAGASSE, E., and WEISSMAN, I.L. (1994). bcl-2 inhibits apoptosis of neutrophils but not their engulfment by macrophages. J. Exp. Med. 179, 1047-1052.
30. BOZIC, C.R., KOLAKOWSKI, L.F., Jr., GERARD, N.P., GARCIA-RODRIGUEZ, C., VON UEXKULL-GULDENBAND, C., CONKLYN, M.J., BRESLOW, R., SHOWELL, H.J., and GERARD, C. (1995). Expression and biologic characterization of the murine chemokine KC. J. Immunol. 154, 6048-6057.
31. CERRETTI, D.P., NELSON, N., KOZLOSKY, C.J., MORRISSEY, P.J., COPELAND, N.G., GILBERT, D.J., JENKINS, N.A., DOSIK, J.K., and MOCK, B.A. (1993). The murine homologue of the human interleukin-8 receptor type B maps near the Ity-Lsh-Bcg disease resistance locus. Genomics 18, 410-413.
32. GEISER, T., DEWALD, B., EHRENGRUBER, M.U., CLARK-LEWIS, I., and BAGGIOLINI, M. (1993). The interleukin-8-related chemotactic cytokines GRO alpha, GRO beta, and GRO gamma activate human neutrophil and basophil leukocytes. J. Biol. Chem. 268, 15419-15424.
33. KOGAN, S.C., LAGASSE, E., ATWATER, S., BAE, S.C., WEISSMAN, I., ITO, Y., and BISHOP, J.M. (1998). The PEBP2betaMYH11 fusion created by Inv(16)(p13;q22) in myeloid leukemia impairs neutrophil maturation and contributes to granulocytic dysplasia. Proc. Natl. Acad. Sci. USA 95, 11863-11868.
34. LAGASSE, E., and WEISSMAN, I. L. (1996). Flow cytometric identification of murine neutrophils and monocytes. J. Immunol. Methods 197, 139-150.
35. BOZIC, C.R., GERARD, N.P., VON UEXKULL-GULDENBAND, C., KOLAKOWSKI, L.F., Jr., CONKLYN, M.J., BRESLOW, R., SHOWELL, H.J., and GERARD, C. (1994). The murine interleukin 8 type B receptor homologue and its ligands. Expression and biological characterization. J. Biol. Chem. 269, 29355-29358.
36. FERNANDEZ, E.J., and LOLIS, E. (2002). Structure, function, and inhibition of chemokines. Annu. Rev. Pharmacol. Toxicol. 42, 469-499.
37. CRUMP, M.P., SPYRACOPOULOS, L., LAVIGNE, P., KIM, K.S., CLARK-LEWIS, I., and SYKES, B.D. (1999). Backbone dynamics of the human CC chemokine eotaxin: fast motions, slow motions, and implications for receptor binding. Protein Sci. 8, 2041-2054.
38. OGBOURNE, S., and ANTALIS, T.M. (1998). Transcriptional control and the role of silencers in transcriptional regulation in eukaryotes. Biochem. J. 331, 1-14.
39. ROBERTSON, G., GARRICK, D., WU, W., KEARNS, M., MARTIN, D., and WHITELAW, E. (1995). Position-dependent variegation of globin transgene expression in mice. Proc. Natl. Acad. Sci. USA 92, 5371-5375.
40. ROBERTSON, G., GARRICK, D., WILSON, M., MARTIN, D.I., and WHITELAW, E. (1996). Age-dependent silencing of globin transgenes in the mouse. Nucleic Acids Res 24, 1465-1471.
41. LAGASSE, E., and WEISSMAN, I.L. (1997). Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell 89, 1021-1031.
42. LAGASSE, E., and CLERC, R.G. (1988). Cloning and expression of two human genes encoding calcium-binding proteins that are regulated during myeloid differentiation. Mol. Cell. Biol. 8, 2402-2410.
43. DANKNER, W.M., McCUTCHAN, J.A., RICHMAN, D.D., HIRATA, K., and SPECTOR, S.A. (1990). Localization of human cytomegalovirus in peripheral blood leukocytes by in situ hybridization. J. Infect. Dis. 161, 31-36.
44. GRUNDY, J.E., LAWSON, K.M., MACCORMAC, L.P., FLETCHER, J.M., and YONG, K.L. (1998). Cytomegalovirus-infected endothelial cells recruit neutrophils by the secretion of C-X-C chemokines and transmit virus by direct neutrophil-endothelial cell contact and during neutrophil transendothelial migration. J. Infect. Dis. 177, 1465-1474.
45. HO, M. (1991). Cytomegalovirus: Biology and Infection, 2nd ed. New York: Plenum Publishing Corp.
46. REVELLO, M.G., ZAVATTONI, M., SARASINI, A., PERCIVALLE, E., SIMONCINI, L., and GERNA, G. (1998). Human cytomegalovirus in blood of immunocompetent persons during primary infection: prognostic implications for pregnancy. J. Infect. Dis. 177, 1170-1175.
47. STODDART, C.A., CARDIN, R.D., BONAME, J.M., MANNING, W.C., ABENES, G.B., and MOCARSKI, E.S. (1994). Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus. J. Virol. 68, 6243-6253.